MicroLight Corporation of America is the worldwide leader in laser therapy and the first company with FDA clearance of low-level laser therapy for the non-surgical treatment of pain through adjunctive therapy.
A pioneer for over 30 years
Established in 1990, MicroLight Corporation of America is the world leader in laser therapy; and the first company with FDA clearance to market low-level laser therapy (“LLLT”) for the non-surgical treatment of pain through adjunctive therapy in patients with Carpal Tunnel Syndrome. MicroLight is a pioneer in the field of cold laser therapy with the patented 830 nanometer(nm) wavelength in a Gallium-Aluminum-Arsenide (GaAIAs) laser. There are 30+ years of clinical studies published on PubMed documenting that the 830nm range is the optimal wavelength to treat pain and inflammation.
Not All Lasers Are the Same.
“Cold laser has become a buzzword. Many people use this term very loosely, but not all lasers are the same. A pointer laser is a laser but has no medical benefit.
The wavelength of the laser is what is important because some wavelengths are beneficial and some are not. The wavelength and the power behind it determine the depth of penetration into the body. The cold laser we use has the deepest penetration power into the body, the MicroLight 830. This laser penetrates 2 inches into the body. The laser beam is a light that helps the mitochondria of the cell produce the energy needed to create healthy new cells more rapidly. – Dr. Carey Girgis, Back Pain Relief Ohio